List of Tables
    Table 1. Choroidal Neovascularization CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Choroidal Neovascularization Market Trends
    Table 3. Choroidal Neovascularization Market Drivers
    Table 4. Choroidal Neovascularization Market Challenges
    Table 5. Choroidal Neovascularization Market Restraints
    Table 6. Global Choroidal Neovascularization Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Choroidal Neovascularization Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Choroidal Neovascularization Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Choroidal Neovascularization Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Choroidal Neovascularization Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Choroidal Neovascularization Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Choroidal Neovascularization Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Choroidal Neovascularization Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Choroidal Neovascularization Sales Share by Manufacturer, 2017-2022
    Table 15. Global Choroidal Neovascularization Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Choroidal Neovascularization Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Choroidal Neovascularization by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2021)
    Table 18. Top Players of Choroidal Neovascularization in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Choroidal Neovascularization Product Type
    Table 20. Date of International Manufacturers Enter into Choroidal Neovascularization Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Choroidal Neovascularization Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Choroidal Neovascularization Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Choroidal Neovascularization Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Choroidal Neovascularization Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Choroidal Neovascularization Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Choroidal Neovascularization Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Choroidal Neovascularization Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Choroidal Neovascularization Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Choroidal Neovascularization Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Choroidal Neovascularization Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Choroidal Neovascularization Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Choroidal Neovascularization Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Choroidal Neovascularization Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Choroidal Neovascularization Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Choroidal Neovascularization Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Choroidal Neovascularization Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Choroidal Neovascularization Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Choroidal Neovascularization Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Choroidal Neovascularization Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Choroidal Neovascularization Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Inc. Corporation Information
    Table 43. Pfizer Inc. Description and Business Overview
    Table 44. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Pfizer Inc. Choroidal Neovascularization Product
    Table 46. Pfizer Inc. Recent Development
    Table 47. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 48. F. Hoffmann-La Roche Ltd. Description and Business Overview
    Table 49. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. F. Hoffmann-La Roche Ltd. Product
    Table 51. F. Hoffmann-La Roche Ltd. Recent Development
    Table 52. Novartis AG Corporation Information
    Table 53. Novartis AG Description and Business Overview
    Table 54. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Novartis AG Product
    Table 56. Novartis AG Recent Development
    Table 57. Regeneron Pharmaceuticals Inc. Corporation Information
    Table 58. Regeneron Pharmaceuticals Inc. Description and Business Overview
    Table 59. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Regeneron Pharmaceuticals Inc. Product
    Table 61. Regeneron Pharmaceuticals Inc. Recent Development
    Table 62. Bayer AG Corporation Information
    Table 63. Bayer AG Description and Business Overview
    Table 64. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Bayer AG Product
    Table 66. Bayer AG Recent Development
    Table 67. QLT Inc. Corporation Information
    Table 68. QLT Inc. Description and Business Overview
    Table 69. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. QLT Inc. Product
    Table 71. QLT Inc. Recent Development
    Table 72. Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
    Table 73. Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
    Table 74. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Sanwa Kagaku Kenkyusho Co. Ltd. Product
    Table 76. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Development
    Table 77. Promedior Inc. Corporation Information
    Table 78. Promedior Inc. Description and Business Overview
    Table 79. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Promedior Inc. Product
    Table 81. Promedior Inc. Recent Development
    Table 82. Bausch Health Corporation Information
    Table 83. Bausch Health Description and Business Overview
    Table 84. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Bausch Health Product
    Table 86. Bausch Health Recent Development
    Table 87. Gilead Sciences Inc Corporation Information
    Table 88. Gilead Sciences Inc Description and Business Overview
    Table 89. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Gilead Sciences Inc Product
    Table 91. Gilead Sciences Inc Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Choroidal Neovascularization Customers List
    Table 95. Choroidal Neovascularization Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Choroidal Neovascularization Product Picture
    Figure 2. Global Choroidal Neovascularization Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Choroidal Neovascularization Market Size 2017-2028 (US$ Million)
    Figure 4. Global Choroidal Neovascularization Sales 2017-2028 (K Units)
    Figure 5. United States Choroidal Neovascularization Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Choroidal Neovascularization Market Size 2017-2028 (US$ Million)
    Figure 7. United States Choroidal Neovascularization Sales 2017-2028 (K Units)
    Figure 8. United States Choroidal Neovascularization Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Choroidal Neovascularization Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Choroidal Neovascularization Report Years Considered
    Figure 11. Product Picture of Intravenous
    Figure 12. Product Picture of Intravitreal
    Figure 13. Global Choroidal Neovascularization Market Share by Type in 2022 & 2028
    Figure 14. Global Choroidal Neovascularization Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Choroidal Neovascularization Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Choroidal Neovascularization Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Choroidal Neovascularization Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Choroidal Neovascularization Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Choroidal Neovascularization Market Share by Type in 2022 & 2028
    Figure 20. United States Choroidal Neovascularization Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Choroidal Neovascularization Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Choroidal Neovascularization Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Choroidal Neovascularization Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Choroidal Neovascularization Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Extreme Myopia
    Figure 26. Product Picture of Malignant Myopic Degeneration
    Figure 27. Product Picture of Age-Related Developments
    Figure 28. Global Choroidal Neovascularization Market Share by Application in 2022 & 2028
    Figure 29. Global Choroidal Neovascularization Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Choroidal Neovascularization Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Choroidal Neovascularization Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Choroidal Neovascularization Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Choroidal Neovascularization Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Choroidal Neovascularization Market Share by Application in 2022 & 2028
    Figure 35. United States Choroidal Neovascularization Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Choroidal Neovascularization Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Choroidal Neovascularization Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Choroidal Neovascularization Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Choroidal Neovascularization Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Choroidal Neovascularization Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Choroidal Neovascularization Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. United States Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Mexico Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Choroidal Neovascularization Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Choroidal Neovascularization Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. UK Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Choroidal Neovascularization Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Choroidal Neovascularization Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Vietnam Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Choroidal Neovascularization Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Choroidal Neovascularization Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Choroidal Neovascularization Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Choroidal Neovascularization Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Choroidal Neovascularization Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Choroidal Neovascularization Value Chain
    Figure 75. Choroidal Neovascularization Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed